Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
2
×
harvard pilgrim health care
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
achromatopsia
akcea therapeutics
alnylam pharmaceuticals
beta-thalassemia
bill cassidy
bluebird bio
boston
clinical trials
deals
dna
drugs
european medicines agency
gene therapy
hemophilia
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
johnson & johnson
luxturna
mark warner
mathai mammen
medicaid
meiragtx
new york
novartis
onpattro
patient affordability value and efficiency act
patisiran
pfizer
san diego blog main
san diego top stories
What
gene
2
×
age
alnylam
approves
bigger
biggest
cells
come
deal
drug
ema
emerging
employ
europe
fda
follows
gave
harmful
hits
interference
j
johnson
make
medicine
meiragtx
method
morning
mute
past
protein
rna
rnai
signal
signals
therapy
uses
way
years
Language
Current search:
fda
×
" harvard pilgrim health care "
×
gene
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
